Advertisement

Pituitary

, Volume 22, Issue 1, pp 54–61 | Cite as

IgG4-related hypophysitis in patients with autoimmune pancreatitis

  • Keitaro Kanie
  • Hironori Bando
  • Genzo Iguchi
  • Hideyuki Shiomi
  • Atsuhiro Masuda
  • Hidenori Fukuoka
  • Hitoshi Nishizawa
  • Yasunori Fujita
  • Arata Sakai
  • Takashi Kobayashi
  • Yuuki Shiomi
  • Kenichi Yoshida
  • Ryusaku Matsumoto
  • Kentaro Suda
  • Yuzo Kodama
  • Wataru Ogawa
  • Yutaka TakahashiEmail author
Article

Abstract

Purpose

IgG4-related disease involves various organs including the pituitary and pancreas. The prevalence of IgG4-related hypophysitis is relatively rare compared with IgG4-related pancreatitis (autoimmune pancreatitis). Although several cases demonstrating both autoimmune pancreatitis and hypophysitis have been reported, the prevalence of IgG4-related hypophysitis in patients with autoimmune pancreatitis remains unknown. This study aimed at screening for IgG4-related hypophysitis to accurately determine its prevalence in patients with autoimmune pancreatitis.

Methods

In this cohort study, we screened IgG4-related hypophysitis via pituitary magnetic resonance imaging (MRI) and endocrinological examination in 27 patients who were undergoing follow-up for autoimmune pancreatitis at Kobe University Hospital between 2014 and 2018.

Results

Among 27 patients with autoimmune pancreatitis, 5 patients exhibited morphological abnormalities in the pituitary (18.5%). Among them, one patient (3.7%) met the criteria for hypophysitis with an enlarged pituitary and stalk concomitant with hypopituitarism. After glucocorticoid treatment, the enlarged pituitary shrank and became empty sella during the clinical course. Four patients (14.8%) revealed empty sella without obvious pituitary dysfunction. Four of 5 patients with morphological pituitary abnormalities showed multiple organ involvement in addition to pancreatic and pituitary involvement. Accordingly, multiple organ involvement was more prevalent in patients with morphological pituitary abnormalities (80%) compared to those without (48%).

Conclusions

Although a large-scale study is necessary to validate these results, these data suggest that the prevalence of hypophysitis in patients with autoimmune pancreatitis may be underestimated. Based on our findings, we recommend screening for hypophysitis, especially in patients with multiple organ involvement.

Keywords

Hypophysitis IgG4-related hypophysitis Autoimmune pancreatitis IgG4-related pancreatitis 

Notes

Acknowledgements

We thank K. Imura and C. Ogata for their excellent assistance.

Author contributions

KK, HB, and GI performed analysis and interpretation of data and wrote the draft of the article. HS, AM, AS, TK, YS, and YK contributed to the preparation of the patient cohort. HF, HN, KY, RM, KS, and WO contributed to the assembly of data. YT contributed to the study supervision and critical revision of the article for important intellectual content.

Funding

This work was supported by Japan Society for the Promotion of Science (JSPS) (KAKENHI, Grant numbers 23659477 and 26670459 [Y Takahashi], 23591354, 15K09431, and 18K08514 [G Iguchi], and 17K16165 [H Bando]), the Foundation for Growth Science (G Iguchi), the Japan Agency for Medical Research and Development (AMED) (17bm0804012h0001) (Y Takahashi), the Uehara Memorial Foundation (Y Takahashi), and the Naito Foundation (Y Takahashi).

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest associated with this research.

Supplementary material

11102_2018_930_MOESM1_ESM.docx (21 kb)
Supplementary material 1 (DOCX 20 KB)

References

  1. 1.
    Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344(10):732–738.  https://doi.org/10.1056/nejm200103083441005 CrossRefGoogle Scholar
  2. 2.
    Kamisawa T, Zen Y, Pillai S, Stone JH (2015) IgG4-related disease. Lancet 385(9976):1460–1471.  https://doi.org/10.1016/s0140-6736(14)60720-0 CrossRefGoogle Scholar
  3. 3.
    Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H (2011) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol 22(1):21–30.  https://doi.org/10.1007/s10165-011-0571-z CrossRefGoogle Scholar
  4. 4.
    Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22(1):1–14.  https://doi.org/10.1007/s10165-011-0508-6 CrossRefGoogle Scholar
  5. 5.
    van der Vliet HJ, Perenboom RM (2004) Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med 141(11):896–897CrossRefGoogle Scholar
  6. 6.
    Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96(7):1971–1980.  https://doi.org/10.1210/jc.2010-2970 CrossRefGoogle Scholar
  7. 7.
    Shimatsu A, Oki Y, Fujisawa I, Sano T (2009) Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 56(9):1033–1041CrossRefGoogle Scholar
  8. 8.
    Bando H, Iguchi G, Fukuoka H, Taniguchi M, Yamamoto M, Matsumoto R, Suda K, Nishizawa H, Takahashi M, Kohmura E, Takahashi Y (2014) The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur J Endocrinol 170(2):161–172.  https://doi.org/10.1530/eje-13-0642 CrossRefGoogle Scholar
  9. 9.
    Shikuma J, Kan K, Ito R, Hara K, Sakai H, Miwa T, Kanazawa A, Odawara M (2017) Critical review of IgG4-related hypophysitis. Pituitary 20(2):282–291.  https://doi.org/10.1007/s11102-016-0773-7 CrossRefGoogle Scholar
  10. 10.
    Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E (2007) Hypopituitarism. The Lancet 369(9571):1461–1470.  https://doi.org/10.1016/s0140-6736(07)60673-4 CrossRefGoogle Scholar
  11. 11.
    Hattori Y, Tahara S, Ishii Y, Kitamura T, Inomoto C, Osamura RY, Teramoto A, Morita A (2013) A case of IgG4-related hypophysitis without pituitary insufficiency. J Clin Endocrinol Metab 98(5):1808–1811.  https://doi.org/10.1210/jc.2013-1088 CrossRefGoogle Scholar
  12. 12.
    Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, Kim MH, Kloppel G, Lerch MM, Lohr M, Notohara K, Okazaki K, Schneider A, Zhang L (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40(3):352–358.  https://doi.org/10.1097/MPA.0b013e3182142fd2 CrossRefGoogle Scholar
  13. 13.
    Okazaki K, Chiba T (2002) Autoimmune related pancreatitis. Gut 51(1):1–4CrossRefGoogle Scholar
  14. 14.
    Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, Hizuka N, Teramoto A, Tatsumi KI, Tachibana K, Katsumata N, Horikawa R (2012) Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J 59(9):771–780CrossRefGoogle Scholar
  15. 15.
    Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(11):3888–3921.  https://doi.org/10.1210/jc.2016-2118 CrossRefGoogle Scholar
  16. 16.
    Chihara K, Shimatsu A, Hizuka N, Tanaka T, Seino Y, Katofor Y (2007) A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. Eur J Endocrinol 157(1):19–27.  https://doi.org/10.1530/eje-07-0066 CrossRefGoogle Scholar
  17. 17.
    Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. The Lancet 357(9254):425–431.  https://doi.org/10.1016/s0140-6736(00)04006-x CrossRefGoogle Scholar
  18. 18.
    Nishimori I, Onishi S, Otsuki M (2008) Review of diagnostic criteria for autoimmune pancreatitis; for establishment of international criteria. Clin J Gastroenterol 1(1):7–17.  https://doi.org/10.1007/s12328-008-0002-7 CrossRefGoogle Scholar
  19. 19.
    Nakasone Y, Oguchi K, Sato Y, Okubo Y, Yamauchi K, Aizawa T (2015) Rapid conversion of autoimmune hypophysitis to an empty sella with immediate lowering of the serum IgG4 level. Case Report. Neuro Endocrinol Lett 36(2):112–114Google Scholar
  20. 20.
    Gao H, Gu YY, Qiu MC (2013) Autoimmune hypophysitis may eventually become empty sella. Neuro Endocrinol Lett 34(2):102–106Google Scholar
  21. 21.
    Lin W, Lu S, Chen H, Wu Q, Fei Y, Li M, Zhang X, Tian X, Zheng W, Leng X, Xu D, Wang Q, Shen M, Wang L, Li J, Wu D, Zhao L, Wu C, Yang Y, Peng L, Zhou J, Wang Y, Sha Y, Huang X, Jiao Y, Zeng X, Shi Q, Li P, Zhang S, Hu C, Deng C, Li Y, Zhang S, Liu J, Su J, Hou Y, Jiang Y, You X, Zhang H, Yan L, Zhang W, Zhao Y, Zeng X, Zhang F, Lipsky PE (2015) Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford) 54(11):1982–1990.  https://doi.org/10.1093/rheumatology/kev203 CrossRefGoogle Scholar
  22. 22.
    Taniguchi T, Hamasaki A, Okamoto M (2006) A case of suspected lymphocytic hypophysitis and organizing pneumonia during maintenance therapy for autoimmune pancreatitis associated with autoimmune thrombocytopenia. Endocr J 53(4):563–566CrossRefGoogle Scholar
  23. 23.
    Wong S, Lam WY, Wong WK, Lee KC (2007) Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 38(11):1720–1723.  https://doi.org/10.1016/j.humpath.2007.06.011 CrossRefGoogle Scholar
  24. 24.
    Ralli S, Lin J, Farrell J (2007) Autoimmune pancreatitis. N Engl J Med 356(15):1586CrossRefGoogle Scholar
  25. 25.
    Tsuboi H, Inokuma S, Setoguchi K, Shuji S, Hagino N, Tanaka Y, Yoshida N, Hishima T, Kamisawa T (2008) Inflammatory pseudotumors in multiple organs associated with elevated serum IgG4 level: recovery by only a small replacement dose of steroid. Intern Med 47(12):1139–1142CrossRefGoogle Scholar
  26. 26.
    Iseda I, Hida K, Tone A, Tenta M, Shibata Y, Matsuo K, Yamadori I, Hashimoto K (2014) Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis. Endocr J 61(2):195–203CrossRefGoogle Scholar
  27. 27.
    Joshi D, Jager R, Hurel S, Pereira SP, Johnson GJ, Chapman M, Fowler R, Winstanley A, Losseff N, Webster GJ (2015) Cerebral involvement in IgG4-related disease. Clin Med (Lond) 15(2):130–134.  https://doi.org/10.7861/clinmedicine.15-2-130 CrossRefGoogle Scholar
  28. 28.
    Koenigstein D, Neudorfer M, Goldenberg D, Habot-Wilner Z (2016) Choroidal effusion as an ocular manifestation of immunoglobulin g4-related disease. Retin Cases Brief Rep 10(3):197–200.  https://doi.org/10.1097/icb.0000000000000223 CrossRefGoogle Scholar
  29. 29.
    Liu Y, Wang L, Zhang W, Pan H, Yang H, Deng K, Lu L, Yao Y, Chen S, Chai X, Feng F, You H, Jin Z, Zhu H (2018) Hypophyseal involvement in immunoglobulin G4-related disease: a retrospective study from a single tertiary center. Int J Endocrinol 2018:7637435.  https://doi.org/10.1155/2018/7637435 Google Scholar
  30. 30.
    Debnath J, Ravikumar R, Sharma V, Senger KP, Maurya V, Singh G, Sharma P, Khera A, Singh A (2016) ‘Empty sella’ on routine MRI studies: an incidental finding or otherwise? Medical journal. Armed Forces India 72(1):33–37.  https://doi.org/10.1016/j.mjafi.2015.11.012 CrossRefGoogle Scholar
  31. 31.
    Honegger J, Buchfelder M, Schlaffer S, Droste M, Werner S, Strasburger C, Stormann S, Schopohl J, Kacheva S, Deutschbein T, Stalla G, Flitsch J, Milian M, Petersenn S, Elbelt U (2015) Treatment of primary hypophysitis in Germany. J Clin Endocrinol Metab 100(9):3460–3469.  https://doi.org/10.1210/jc.2015-2146 CrossRefGoogle Scholar
  32. 32.
    Andrioli M, Pecori Giraldi F, Cavagnini F (2006) Isolated corticotrophin deficiency. Pituitary 9(4):289–295.  https://doi.org/10.1007/s11102-006-0408-5 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Keitaro Kanie
    • 1
  • Hironori Bando
    • 1
  • Genzo Iguchi
    • 2
  • Hideyuki Shiomi
    • 3
  • Atsuhiro Masuda
    • 3
  • Hidenori Fukuoka
    • 2
  • Hitoshi Nishizawa
    • 1
  • Yasunori Fujita
    • 1
  • Arata Sakai
    • 3
  • Takashi Kobayashi
    • 3
  • Yuuki Shiomi
    • 3
  • Kenichi Yoshida
    • 1
  • Ryusaku Matsumoto
    • 1
  • Kentaro Suda
    • 1
  • Yuzo Kodama
    • 3
  • Wataru Ogawa
    • 1
  • Yutaka Takahashi
    • 1
    Email author
  1. 1.Division of Diabetes and Endocrinology, Department of Internal MedicineKobe University Graduate School of MedicineKobeJapan
  2. 2.Division of Diabetes and EndocrinologyKobe University HospitalKobeJapan
  3. 3.Division of Gastroenterology, Department of Internal MedicineKobe University Graduate School of MedicineKobeJapan

Personalised recommendations